Combination Treatment for Peritoneal Mesothelioma Increases Survival Rate
Researchers reported in December that through a combination of surgery and chemotherapy used as a “bath” applied directly to the cancer site, they have improved the survival rate for patients suffering from peritoneal mesothelioma.
Mesothelioma, a cancer caused by asbestos exposure, can affect the lining of the lungs known as pleural mesothelioma, or the lining of the abdomen resulting in peritoneal mesothelioma. In rare instances, the lining of the heart can be affected resulting in pericardial mesothelioma. There is no known cure for the disease.
Researchers at eight medical research universities throughout the world including the U.S., Italy, and Australia, collaborated on the study and reported that of the patients treated for peritoneal mesothelioma, the overall median survival rate was 53 months, and 47 percent of the patients were alive after five years.
After surgery to remove the cancerous tumors from the lining of the abdomen, the doctors then used procedure called hyperthermic interperitoneal chemotherapy. The patient’s abdominal cavity was bathed for several hours in a heated chemotherapy solution to treat remaining cancer cells while the patient was in the operating room.
The researchers said that the improved survival rate could be attributed to the absence of cancer having spread to the lymph nodes, the completeness of the tumor removal and the chemotherapy treatment. The treatment can also help reduce pain associated with mesothelioma.
Combo Treatment for Mesothelioma in Abdomen Helps Some Patients Live Longer